Scipher Medicine Strengthens Leadership Team with Appointment of Sam A Davis, JD as General Counsel

Sep 24, 2021

SEPTEMBER 24, WALTHAM, MA – Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announces the appointment of Sam A. Davis, JD, as General Counsel. Sam will lead all legal matters, including strategic...

Ventegra Partners with Scipher Medicine For Patient-Centric Approach To Improve Outcomes and Lower Costs for Rheumatoid Arthritis Care

Sep 16, 2021

SEPTEMBER 16, 2021 – WALTHAM, MA Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with Ventegra, Inc., a new class-of-trade Medical Benefits Manager that uses innovative...

Scipher Medicine Increases Patient Access for PrismRA^® by Expanding Intended Use in Autoimmune Patients

Jul 29, 2021

Expanded intended use for the blood test validated in Network-004 study.Now, most rheumatoid arthritis patients can be tested at any point in their clinical journey.Test enables providers to identify optimal rheumatoid arthritis treatment for more than 600,000...

Scipher Medicine Announces PrismRA^® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug Class, TNFi

Jun 24, 2021

Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with TherapyProviders Can Access Patient-Specific Data for Optimized Therapy Selection JUNE 24, 2021 – WALTHAM, MA – Scipher Medicine, a precision immunology company matching...

Scipher Medicine Presents New Data at the European League Against Rheumatism (EULAR) 2021 Further Validating PrismRA^® Test

Jun 15, 2021

Molecular signature test predicts likelihood of non-response to adalimumab or etanercept, two of the world’s most expensive medications, in an independent validation cohortPrismRA demonstrates a more efficient therapy selection protocol beyond current standardThree...

Scipher Medicine and Leading Medical Researchers in Network and Data Science Compress Time to Identify Covid-19 Treatments from Years to Months

Jun 8, 2021

Study demonstrates Scipher Medicine’s ability to analyze patient data to identify novel treatments.Scipher will focus on pharma collaborations in autoimmune diseases. June 8, 2021 – WALTHAM, MA – Scipher Medicine, a precision immunology company matching patients with...